Basel Medical Group Ltd (NASDAQ:BMGL) Stock Short Interest Jumps 1,917.0%

Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 159,585 shares, a growth of 1,917.0% from the August 31st total of 7,912 shares. Based on an average trading volume of 3,135,507 shares, the days-to-cover ratio is currently 0.1 days. Currently, 10.1% of the company’s shares are sold short.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered shares of Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, September 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Check Out Our Latest Research Report on Basel Medical Group

Basel Medical Group Stock Down 7.1%

BMGL stock traded down $0.29 during midday trading on Thursday, hitting $3.80. The company’s stock had a trading volume of 61,502 shares, compared to its average volume of 209,493. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.83 and a current ratio of 1.88. Basel Medical Group has a 52-week low of $3.70 and a 52-week high of $22.20. The firm has a 50-day simple moving average of $5.20 and a 200-day simple moving average of $6.57.

Basel Medical Group (NASDAQ:BMGL – Get Free Report) last posted its quarterly earnings results on Friday, June 26th. The company reported $0.01 EPS for the quarter. The business had revenue of $3.21 million during the quarter.

Basel Medical Group Company Profile

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

See Also

Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.